Patents by Inventor Filip Krag Knop

Filip Krag Knop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210340211
    Abstract: Provided herein are glucose-dependent insulinotropic polypeptide (GIP)-derived peptide analogues, for example GIP(3-30), and their use as antagonists of the GIP receptor and for treatment of disorders such as obesity, diabetes mellitus and insulin resistance.
    Type: Application
    Filed: March 1, 2021
    Publication date: November 4, 2021
    Inventors: Alexander Hovard Sparre-Ulrich, Mette Marie Rosenkilde, Jens Juul Holst, Filip Krag Knop, Mikkel Bring Christensen, Laerke Smidt Gasbjerg
  • Patent number: 10968266
    Abstract: Provided herein are glucose-dependent insulinotropic polypeptide (GIP)-derived peptide analogues, for example GIP(3-30), and their use as antagonists of the GIP receptor and for treatment of disorders such as obesity, diabetes mellitus and insulin resistance.
    Type: Grant
    Filed: September 7, 2015
    Date of Patent: April 6, 2021
    Assignee: UNIVERSITY OF COPENHAGEN
    Inventors: Alexander Hovard Sparre-Ulrich, Mette Marie Rosenkilde, Jens Juul Holst, Filip Krag Knop, Mikkel Bring Christensen, Lærke Smidt Gasbjerg
  • Publication number: 20180258152
    Abstract: Provided herein are glucose-dependent insulinotropic polypeptide (GIP)-derived peptide analogues, for example GIP(3-30), and their use as antagonists of the GIP receptor and for treatment of disorders such as obesity, diabetes mellitus and insulin resistance.
    Type: Application
    Filed: September 7, 2015
    Publication date: September 13, 2018
    Applicant: University of Copenhagen
    Inventors: Alexander Hovard Sparre-Ulrich, Mette Marie Rosenkilde, Jens Juul Holst, Filip Krag Knop, Mikkel Bring Christensen, Lærke Smidt Gasbjerg